Home > Inhibitors & Agonists > Antibiotics and Antivirals > HIV
Cat. No. Product name CAS No.
DC12012 PD 404182

A heterocyclic iminobenzothiazine derivative with antimicrobial and anti-inflammatory properties, a potent inhibitor of human DDAH1 activity (IC50=9 uM) and elevates cellular ADMA levels.

72596-74-8
DC11892 Elsulfavirine

A new-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) for the treatment of HIV-1 infections, the prodrug of the active compound VM-1500A..

868046-19-9
DC11628 HIV-1 Integrase Inhibitor 1

A novel compound that disrupts the HIV-1 integrase LEDGF interaction.

2146094-22-4
DC11854 IDX899

A novel potent, selective HIV non-nucleoside reverse transcriptase inhibitor (NNRTI) with EC50 of 1, 1.3, 2.8 and 11 nM for WT, K103N, Y181C and K103N/Y181C, respectively.

1018450-26-4
DC11807 HIV InSTI-1

A potent HIV integrase strand transfer inhibitor (InSTIs) with IC50 of 8 nM in HIV replication assay.

1549802-58-5
DC11806 MK-0536

A potent HIV-1 integrase strand transfer inhibitor with IC50 of 33 nM, 9.5 nM, 40 nM, 20 nM and 237 nM for wt IN, IN Y143R, IN N155H, G118R and IN G140S-Q148H, respectively.

865298-81-3
DC9029 Abacavir

Abacavir is a powerful nucleoside analog reverse transcriptase inhibitor (NRTI) used to treat HIV and AIDS.

136470-78-5
DC7058 Amprenavir

Amprenavir (Agenerase) is a HIV protease inhibitor(Ki=0.6 nM) used to treat HIV infection.

161814-49-9
DC3150 Atazanavir

Atazanavir is a HIV protease inhibitor with Ki of 2.66 nM.

198904-31-3
DC9480 Atazanavir (sulfate)

Atazanavir sulfate is a sulfate salt form of atazanavir that is an highly potent HIV-1 protease inhibitor.

229975-97-7
DC10890 Bictegravir Featured

Bictegravir is a novel, potent inhibitor of HIV-1 integrase with an IC50 of 7.5 nM.

1611493-60-7
DC7007 BMS-538203

BMS-538203 is a highly efficient HIV integrase inhibitor and antiviral agent.

543730-41-2
DC9700 BMS-707035 Featured

BMS-707035 is a potent, specific, and reversible HIV-I integrase (IN) inhibitor that blocks HIV IN strand transfer activity.

729607-74-3
DC8908 Darunavir ethanolate Featured

Darunavir ethanolate is an HIV protease inhibitor,showed potent activity against COVID-19(SARS-COV-2).

635728-49-3
DC11352 Delavirdine (mesylate)

Delavirdine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that selectively inhibits HIV-1 reverse transcriptase over DNA polymerase α and δ in vitro (IC50s = 0.26, 440, and >550 μM, respectively).

147221-93-0
DC8897 Delavirdine

Delavirdine(U 90152) is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI).

136817-59-9
DC7273 Dolutegravir Featured

Dolutegravir (DTG, GSK1349572) is an integrase inhibitor(IC50= 2.7 nM), modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H.

1051375-16-6
DC10250 Dolutegravir Sodium Featured

Dolutegravir is a HIV integrase inhibitor with IC50 of 2.7 nM.

1051375-19-9
DC9308 Doravirine (MK-1439)

Doravirine (MK-1439) is a non-nucleoside reverse transcriptase inhibitor.

1338225-97-0
DCAPI1479 Efavirenz

Efavirenz is a nonnucleoside HIV-1 reverse transcriptase (RT) inhibitor which selectively inhibits the glucuronidation of 3'-Azido-3'-deoxythymidine β-D-glucuronide, Sodium Salt. Studies suggest that Efavirenz binds to a distinct site of reverse transcrip

154598-52-4
DC5902 Emtricitabine

Emtricitabine is a nucleoside analogue which inhibits the reverse nucleoside transcriptase enzyme. Structurally this antiviral agent is similar to Lamivudine. This agent is effective at targeting HIV and HBV viruses since these viruses replicate in a reve

143491-57-0
DC4234 Etravirine

Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) of human immunodeficiency virus type 1 (HIV-1).

269055-15-4
Page 1 / Total 3 FirstPrevNextLastGoto